Skip to content
value.today

Clearside Biomedical, Inc. vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $92 M for Clearside Biomedical, Inc., 980 times as much (market caps of Jan 5, 2024 for Clearside Biomedical, Inc. and Oct 30, 2026 for Moderna, Inc.). Clearside Biomedical, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $8 M for Clearside Biomedical, Inc.
  • Both made a net loss: $18 M for Clearside Biomedical, Inc. and $2.8 B for Moderna, Inc.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -233.3% for Clearside Biomedical, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Clearside Biomedical, Inc. 78Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Moderna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureClearside Biomedical, Inc.
CLSD
Moderna, Inc.
MRNA · #274 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20112010
Size
Market cap$92 M*$90.1 B
Revenue$8 M$1.9 B
Net income$-18 M▲ best$-2.8 B
Employees—4,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jan 2024Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Clearside Biomedical, Inc. or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $92 M for Clearside Biomedical, Inc., 980 times as much (market caps of Jan 5, 2024 for Clearside Biomedical, Inc. and Oct 30, 2026 for Moderna, Inc.). Clearside Biomedical, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Clearside Biomedical, Inc. or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $8 M for Clearside Biomedical, Inc. Both made a net loss: $18 M for Clearside Biomedical, Inc. and $2.8 B for Moderna, Inc.

Which is more profitable, Clearside Biomedical, Inc. or Moderna, Inc.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -233.3% for Clearside Biomedical, Inc.